August 20, 2020
This article was originally published by Cancer Therapy Advisor In the COVID-19 era, oncologists have had to reimagine routine cancer care and follow-up care, especially for patients who are immunocompromised. Among the top priorities: finding the right balance between high-quality cancer treatment and limiting patients’ exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For...
Continue Reading
This article was originally published by Targeted Oncology As part of a virtual Case Based Peer Perspective event, Jesus G. Berdeja, MC, director of Myeloma Research, Sarah Cannon Research Institute, in Nashville, Tennesee, discussed the treatment options for stage II multilple myeloma, based on a case of a 71-year female patient. Targeted Oncology™: Is this...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand